• Dual‑receptor GIP/GLP‑1 mechanism offers strong glucose lowering and weight control.
• Once‑weekly dose enhances convenience and adherence.
• Clinically tested for both type 2 diabetes and weight‑related comorbidities.
• Injectable formulation bypasses oral absorption challenges.
• Comprehensive metabolic benefits: improved insulin response, reduced appetite, slower gastric emptying.

1. Administer one 5 mg dose subcutaneously, once weekly, in the thigh, upper arm or abdomen as directed by your physician. 
2. Ensure the injection site is clean. Rotate injection sites week‑to‑week to reduce skin irritation.
3. If you miss the scheduled weekly dose and it is within 4 days, inject as soon as you remember and reset your weekly schedule. If beyond 4 days, consult your doctor for guidance. 
4. Combine with a reduced‑calorie diet and increased physical activity for optimal results in glucose control and weight management. 
5. Monitor your blood glucose levels and attend regular follow‑ups to adjust dosage or therapy plan with your doctor.

Q: What is TIRZEE 5 mg used for?
A: It is used for improving blood sugar control in adults with type 2 diabetes, when diet and exercise alone are insufficient.

Q: Can TIRZEE help with weight loss?
A: Yes — studies show tirzepatide also promotes weight reduction when combined with lifestyle changes.

Q: Is the injection once daily or weekly?
A: Once weekly, subcutaneous administration.

Q: How soon will I see effects?
A: Blood glucose improvements may be seen within weeks; significant weight and cardiovascular benefits may require months and consistent use.

Q: Can both men and women use it?
A: Yes — but women planning pregnancy or breastfeeding should talk with their healthcare provider first.

• Use only under prescription from a registered medical practitioner. TIRZEE is a weekly injectable; do not substitute or self‑adjust. 
• May not be suitable for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 (multiple endocrine neoplasia syndrome type 2). 
• If gastrointestinal side‑effects (especially persistent vomiting or symptoms of pancreatitis) occur, seek medical attention. 
• Use with caution when taking other oral medications because TIRZEE delays gastric emptying and may affect absorption of other drugs. 
• Not recommended to share injection pens or reuse single‑dose pens.
• Must be stored and handled per manufacturer instructions to maintain efficacy.